Remove trial restrictions Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Moodys
Colorcon
Baxter
McKinsey

Last Updated: May 17, 2022

CLINICAL TRIALS PROFILE FOR SODIUM ACETATE ANHYDROUS


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Sodium Acetate Anhydrous

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Orphan Europe Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Mayo Clinic Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00302289 ↗ B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients Completed Science, Toxicology & Technology, San Francisco, California Phase 1 2000-01-01 The primary aim was to measure the effect of green tea extract, tyrosine and caffeine on energy expenditure, appetite ratings and spontaneous energy intake together with recording of side effects in healthy normal weight subjects.
NCT00302289 ↗ B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients Completed University of Copenhagen Phase 1 2000-01-01 The primary aim was to measure the effect of green tea extract, tyrosine and caffeine on energy expenditure, appetite ratings and spontaneous energy intake together with recording of side effects in healthy normal weight subjects.
NCT00778557 ↗ Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions Completed Ranbaxy Laboratories Limited N/A 2005-06-01 The study was conducted as a blinded, randomized, 3-way crossover study to compare the single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fasting conditions
NCT00778739 ↗ Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions Completed Ranbaxy Laboratories Limited N/A 2005-06-01 The study was conducted as an open-label, randomized, 2-way crossover study to compare the single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fed conditions
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sodium Acetate Anhydrous

Condition Name

Condition Name for Sodium Acetate Anhydrous
Intervention Trials
Healthy 4
Patients Undergoing Screening or Surveillance Colonoscopy 1
Anatomic Stage IA Breast Cancer AJCC v8 1
Seasonal Allergic Rhinitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sodium Acetate Anhydrous
Intervention Trials
Pachyonychia Congenita 1
Carcinoma 1
Headache 1
Breast Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sodium Acetate Anhydrous

Trials by Country

Trials by Country for Sodium Acetate Anhydrous
Location Trials
United States 25
Canada 3
Spain 3
United Kingdom 2
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sodium Acetate Anhydrous
Location Trials
California 5
Utah 2
Florida 2
Connecticut 2
Pennsylvania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sodium Acetate Anhydrous

Clinical Trial Phase

Clinical Trial Phase for Sodium Acetate Anhydrous
Clinical Trial Phase Trials
Phase 4 4
Phase 3 2
Phase 2/Phase 3 2
[disabled in preview] 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sodium Acetate Anhydrous
Clinical Trial Phase Trials
Completed 15
Not yet recruiting 3
Recruiting 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sodium Acetate Anhydrous

Sponsor Name

Sponsor Name for Sodium Acetate Anhydrous
Sponsor Trials
Ranbaxy Laboratories Limited 2
MetVital, Inc. 2
National Cancer Institute (NCI) 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sodium Acetate Anhydrous
Sponsor Trials
Other 19
Industry 15
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts
Mallinckrodt
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.